Frederick Abbott is Edward Ball Eminent Scholar Professor of International Law at Florida State University College of Law. He has served as expert consultant for numerous international and regional organizations, governments and nongovernmental organizations, mainly in the fields of intellectual property, public health, trade and sustainable development. Professor Abbott is the author of many books and articles in the fields of international intellectual property rights law, public health, international economic law and international law. Recent books include International Intellectual Property in an Integrated World Economy, 3d ed. 2015 (with T. Cottier and F. Gurry)(information below), Emerging Markets and the World Patent Order, ed. with Carlos M. Correa and Peter Drahos (2013)(information below) and Global Pharmaceutical Policy (2009) (with G. Dukes). He is a member of the Expert Advisory Group (EAG) to the High Level Panel on Access to Medicines appointed by the UN Secretary General in late 2015. He is Co-Chair of the Committee on Global Health Law of the International Law Association, having served as Rapporteur for the Committee on International Trade Law from the inception of its work in 1993 to its conclusion in 2014. He is consultant to the World Health Organization, the United Nations Development Program and other multilateral institutions. Professor Abbott is on the editorial board of the Journal of International Economic Law (Oxford). He regularly serves as panelist for the WIPO Arbitration and Mediation Center. He has served as counsel to governments in WTO dispute settlement proceedings, and in national court proceedings. Prior to entering academia, Professor Abbott was partner in a major US law firm and specialized in international business regulation and technology-related transactions. He was based in San Francisco (1977-1983) and Silicon Valley (1984-1989). Professor Abbott is Co-Director of the Executive Course on Intellectual Property, Diplomacy and Global Public Health for the Global Health Programme of the Graduate Institute|Geneva and he teaches on the visiting faculty of the World Trade Institute, Berne, Switzerland. He is a graduate of the Yale Law School and the University of California, Berkeley.
For more information contact: firstname.lastname@example.org
Note: To improve operational capability, this website/hosting is being upgraded. During the transition some menu links are redirected to the previous format/host.
From the Publisher:
Emerging Markets and the World Patent Order
Edited by Frederick M. Abbott, Edward Ball Eminent Scholar Professor of International Law, Florida State University College of Law, US, Carlos M. Correa, Professor and Director, Centre for Interdisciplinary Studies on Industrial Property and Economics (CEIDIE), Law Faculty, University of Buenos Aires, Argentina and Peter Drahos, Professor, Regulatory Institutions Network, The Australian National University and Chair in Intellectual Property, Queen Mary, University of London, UK
Description The patent has emerged as a dominant force in 21st century economic policy. This book examines the impact of the BRICS and other emerging economies on the global patent framework and charts the phenomenal rise in the number of patents in some of these countries.
Contributors include: F.M. Abbott, D. Borges Barbosa, C.M. Correa, P. Drahos, M. El Said, C. Fink, P. Gehl Sampath, K. Karachalios, R. Kher, J. Kuanpoth, A. Kudlinski, T. Payosova, P. Roffe, S.K. Sell, Y. Tamura, G. Van Overwalle, Y.A. Vawda, H. Zhang, W. Zhuang
Submission to Senate Finance Committee on March 3, 2016 in response to request feedback regarding the report on “The Price of Sovaldi and its impact on the U.S. Health Care System”
Global Health Law Committee submissions to UN High Level Panel on Access to Medicines process to be presented in London on March 9, 2016
Peter Gosselin, Obama Pushes Trade Partners to Add Drug Rules He Opposes in U.S., Washington Post/Bloomberg News, July 10, 2015
Soumonty Kanungo, Biased? India has a balanced pharma patent regime, DNA India, June 15, 2015
Anju Ghangurde, Prof Abbott on Lilly's 'borderline absurd' ISDS plaint and the TPP, SCRIP Intelligence, June 10, 2015
Excessive Pharmaceutical Prices and Competition Law: Doctrinal Development to Protect Public Health, forthcoming in UC Irvine Law Review, Volume 6, Issue 3, Spring 2017
Rethinking Patents: From ‘Intellectual Property’ to ‘Private Taxation Scheme’, in KRITIKA: ESSAYS ON INTELLECTUAL PROPERTY, vol. 1, pgs. 1-16 (eds. P. Drahos, G. Ghidini, H. Ullrich), Edward Elgar 2015
Trade in medines, in Trade and Health: Towards building a National Strategy 117-40 (eds. R. Smith et al.), World Health Organization (2015)
Third Contribution to Roundtable on Climate mitigation and intellectual property in tension, Let a thousand technologies bloom (Bulletin of the Atomic Scientists, Mar. 13, 2015)
Second Contribution to Roundtable on Climate mitigation and intellectual property in tension, Aggregating capital, addressing climate change (Bulletin of the Atomic Scientists, Mar. 13, 2015)
Summary Report of Global Health Security Meeting, ILA Global Health Law Committee - Graduate Institute|Geneva Global Health Programme, Feb. 19, 2015
Contribution to Roundtable on Climate mitigation and intellectual property in tension, A problem, but not without solutions (Bulletin of the Atomic Scientists, Feb. 19, 2015)
May 21, 2014 William New interviews Frederick Abbott
Discussing Emerging Markets and the World Patent Order